Method of myelinating isolated motoneurons by Hickman, James
University of Central Florida 
STARS 
UCF Patents Technology Transfer 
9-9-2014 
Method of myelinating isolated motoneurons 
James Hickman 
University of Central Florida 
Find similar works at: https://stars.library.ucf.edu/patents 
University of Central Florida Libraries http://library.ucf.edu 
This Patent is brought to you for free and open access by the Technology Transfer at STARS. It has been accepted for 
inclusion in UCF Patents by an authorized administrator of STARS. For more information, please contact 
STARS@ucf.edu. 
Recommended Citation 
Hickman, James, "Method of myelinating isolated motoneurons" (2014). UCF Patents. 359. 
https://stars.library.ucf.edu/patents/359 
c12) United States Patent 
Hickman et al. 
(54) METHOD OF MYELINATING ISOLATED 
MOTONEURONS 
(75) Inventors: James Hickman, Orlando, FL (US); 
John Rumsey, Orlando, FL (US) 
(73) Assignee: University of Central Florida Research 
Foundation, Inc., Orlando, FL (US) 
( *) Notice: Subject to any disclaimer, the term ofthis 
patent is extended or adjusted under 35 
U.S.C. 154(b) by 540 days. 
(21) Appl. No.: 121788,732 
(22) Filed: May 27, 2010 
Related U.S. Application Data 










CPC ............ C12N 510619 (2013.01); C12N 510622 
(2013.01) 
USPC ........................................... 435/368; 435/373 
(58) Field of Classification Search 
CPC ............................ Cl2N 5/0619; Cl2N 5/0622 
See application file for complete search history. 
(56) References Cited 
U.S. PATENT DOCUMENTS 
5,442,510 A 8/1995 Schwartz ...................... 364/152 
5,948,621 A 9/1999 Turner .............................. 435/6 
6,866,383 B2 3/2005 Naik ............................. 347/105 
6,916,541 B2 7/2005 Pantano ........................ 428/429 
6,935,165 B2 8/2005 Bashir .......................... 73/64.53 
7,384,786 B2 6/2008 Freyman ....................... 435/395 
7,541,146 B2 612009 Lewis ............................... 435/6 
7,579,189 B2 8/2009 Freyman ....................... 435/395 
7,691,629 B2 4/2010 Johe .............................. 435/402 
7,923,015 B2 412011 Vazquez-Martinez ..... 424/192.1 
7,927,671 B2 412011 Kato .............................. 428/1.1 
8,071,319 B2 12/2011 Metzger ......................... 435/7.2 
8,178,602 B2 512012 Mao .............................. 524/109 
8,318,488 Bl 1112012 Bohlen ......................... 435/375 
8,318,489 B2 1112012 Davidson ...................... 435/377 
8,318,951 B2 1112012 Olson ........................ 548/365.7 
2003/0065452 Al 4/2003 Hickman ........................ 702/19 
2003/0144823 Al 7/2003 Fox ................................. 703/11 
2003/0211542 Al 1112003 Lee ................................ 435/7.1 
2006/0105457 Al 512006 Rameshwar .................. 435/368 
2007/0015138 Al 112007 Barlow ............................. 435/4 
2007/0117217 Al 5/2007 Lal ................................ 436/513 
2007/0212723 Al 9/2007 Dudley ............................. 435/6 
2008/0124789 Al 5/2008 Hickman ........................ 702/19 
2008/0227137 Al 9/2008 Zhang ........................... 435/366 
2009/0029463 Al 112009 Collins ......................... 435/366 
I lllll llllllll Ill lllll lllll lllll lllll lllll 111111111111111111111111111111111 
US008828721Bl 
(10) Patent No.: US 8,828,721 Bl 










912009 Del Monte . 514/44 R 
12/2009 Baudenbacher ................ 436/34 
10/2011 Hickman ...................... 435/176 
512012 Hickman .......................... 435/6 
512012 Hickman ...................... 435/525 








































U.S. Appl. No. 60/916,641, filed May 8, 2007, James J. Hickman. 
U.S. Appl. No. 12/117,339, filed May 8, 2008, James J. Hickman. 
U.S. Appl. No. 60/945,952, filed Jun. 25, 2007, James J. Hickman. 
U.S. Appl. No. 12/145,810, filed Jun. 25, 2008, James J. Hickman. 
U.S. Appl. No. 611159,851, filed Mar. 13, 2009, James J. Hickman. 
U.S. Appl. No. 611259,715, filed Nov. 10, 2009, James J. Hickman. 
U.S. Appl. No. 12/661,323, filed Mar. 15, 2010, James J. Hickman. 
U.S. Appl. No. 611171,958, filed Apr. 23, 2009, James J. Hickman. 
U.S. Appl. No. 12/765,996, filed Apr. 23, 2010, James J. Hickman. 
U.S. Appl. No. 611331,999, filed May 6, 2010, James J. Hickman. 
U.S. Appl. No. 611332,003, filed May 6, 2010, James J. Hickman. 
(Continued) 
Primary Examiner - Robert C Hayes 
(74) Attorney, Agent, or Firm - Ballard Spahr LLP 
(57) ABSTRACT 
The present invention provides a method of inducing myeli-
nation ofisolatedmotoneurons by preparing a non-biological 
substrate having thereon a covalently attached monolayer of 
DETA; depositing isolated motoneurons on the substrate in a 
defined serum-free medium; plating isolated Schwarm cells 
cultured in the defined serum-free medium onto the motoneu-
rons, thereby initiating a co-culture; and passaging the co-
culture as necessary into fresh, defined serum-free medium 
supplemented with L-ascorbic acid at least until the motoneu-
rons form Nodes of Ranvier indicative of myelination. The 
invention also includes a method of testing for new drugs 
effective in demyelinating diseases. Additionally, cellular 
products provided by the invention include an isolated moto-
neurons myelinated or remyelinated in vitro according to the 
methods disclosed . 
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METHOD OF MYELINATING ISOLATED 
MOTONEURONS 
RELATED APPLICATION 
This application claims priority from provisional applica-
tion Ser. No. 61/181,737, which was filed on 28 May 2009, 
and which is incorporated herein by reference in its entirety. 
2 
methods to create defined systems to understand hippocam-
pal function [11] and motoneuron regeneration [12]. The 
adaptation of these culture systems to motoneurons/Schwann 
cell co-culture would be an ideal solution to this problem. 
SUMMARY OF THE INVENTION 
One of the most significant interactions between Schwarm 
cells and neurons is myelin sheath formation. Myelination is 
STATEMENT REGARDING FEDERALLY 
SPONSORED RESEARCH OR DEVELOPMENT 
This invention was made with govermnent support under 
ROI NS050452 awarded by the National Institutes of Health. 
The government has certain rights in the invention. 
10 a vertebrate adaptation that enables rapid conduction of 
action potentials without a commensurate increase in axon 
diameter. In vitro neuronal systems provide a unique modal-
ity to study both factors influencing myelination and diseases 
FIELD OF THE INVENTION 
The present invention relates to the field of neurodegenera-
tive diseases and, more particularly, to an in vitro co-culture 
of motoneurons and Schwarm cells which promotes the sur-
vival, maturation and myelinization of the motoneurons with 
subsequent complete node of Ranvier formation. 
15 
associated with myelination. Currently, no in vitro system for 
motoneuron myelination by Schwarm cells has been demon-
strated. This work details the myelination of motoneuron 
axons by Schwarm cells, with complete Node of Ranvier 
formation, in a defined in vitro culture system. This defined 
20 system utilizes a novel serum-free medium in combination 
with the non-biological substrate, N-1[3(trimethoxysilyl) 
propyl]diethylenetriamine (DETA). It should be understood 
that the substrate is also referred to herein as a surface. The 
myelinated segments and nodal proteins were visualized and 
BACKGROUND OF THE INVENTION 25 quantified using confocal microscopy. This defined system 
provides a highly controlled, reproducible model for studying 
Schwarm cell interactions with motoneurons as well as the 
myelination process and its effect on neuronal plasticity. Fur-
The rapid conduction of action potentials in both the cen-
tral nervous system (CNS) and peripheral nervous system 
(PNS) depends on the formation of a myelin sheath around 
neuronal axons. In the PNS, myelination initiation requires an 30 
interaction between Schwarm cells and an individual axon, a 
process known as radial sorting [1]. During myelination, 
Schwarm cells form an insulating, multilamellar sheath 
around associated axonal segments, resulting in the formation 
of four specialized domains: the internode, the juxtaparan- 35 
ode, the paranodal region and the Node of Ranvier. In the 
internode, axons are ensheathed by compact myelin consist-
ing of the Schwarm cell membrane and expressed myelin 
basic protein (MBP). The juxtaparanodal region sits adjacent 
to the paranode and contains localized clusters of voltage- 40 
gated potassium channels (vgpc's) in the axon. In the paran-
odal region, the axon and myelin sheath form axo-glial junc-
tions where Schwarm cells express neurofascin 155 form 
heterodimers along with axonal protein contactin-associated 
protein (CASPR) [2]. At the Nodes of Ranvier, which are 45 
specialized regions of unmyelinated axon between two 
myelin segments, the presence of clusters of voltage-gated 
sodium channels (vgsc's) facilitate the saltatory conduction 
of action potentials [3]. 
Model systems that can represent the myelination of moto- 50 
neurons by glial cells have previously proven difficult to 
develop. Myelination of neurons by Schwarm cells has been 
extensively studied using dorsal root ganglia (DRG) cultures 
in a variety of serum containing and serum-free in vitro sys-
tems [4]. However, while many groups have reported the 55 
successful co-culture of primary motoneurons and Schwarm 
cells, the success of myelinating sensory neuron systems has 
not been translated to motoneuron systems [ 5-1 O]. The devel-
opment of a functional myelinating motoneuron/Schwann 
cell system is a necessary first step in describing the molecu- 60 
lar events surrounding the interactions between these cells 
that have myelination as the end result. Additionally, such a 
system would benefit scientists' ability to study both central 
and peripheral demyelinating neuropathies such as multiple 
sclerosis, Guillain-Barre Syndrome, diabetes associated 65 
peripheral neuropathies and progressive muscular atrophy, 
under controlled conditions. Previous studies have described 
thermore, an in vitro system that would allow studies of 
motoneuron myelination would be beneficial for understand-
ing peripheral demyelinating neuropathies such as diabetes 
induced peripheral neuropathy and could lead to a better 
understanding of CNS demyelinating diseases like multiple 
sclerosis, as well as neuromuscular junction maturation and 
maintenance. 
With the foregoing in mind, the present invention advan-
tageously discloses a system for the myelination of motoneu-
rons in a chemically defined, serum-free medium on the bio-
mimetic, non-biological substrate N-1 [3(trimethoxysilyl) 
propyl]diethylenetriamine (DETA). The utility of this 
substrate comes from its ability to form a self-assembled 
monolayer on any hydroxalated surface [13], the ease of 
photolithographic patterning [14] and the postulation that 
cells do not degrade this surface modification due to its non-
biological origins and covalent attachment to the surface [11, 
15]. In the defined medium we have identified the minimum 
combination of growth factors required for neuronal growth, 
as well as Schwarm cell survival, proliferation and myelina-
tion of motoneuron axons that results in complete Node of 
Ranvier formation. System maturation was determined by 
analysis of the clustering of voltage-gated sodium (vgsc's) 
and potassium channels (vgpc's) at the nodes as well as from 
the presence of contactin-associated protein (CASPR). This 
defined system provides a reproducible model for studying 
Schwarm cell interactions with motoneurons as well as the 
myelination process, and most importantly, remyelination. 
Accordingly, the present invention provides a method of 
inducing myelination of isolated motoneurons. A preferred 
method of the invention includes preparing a non-biological 
substrate having thereon a covalently attached monolayer of 
DETA; depositing isolated motoneurons on the substrate in a 
defined serum-free medium; plating isolated Schwarm cells 
cultured in the defined serum-free medium onto the motoneu-
rons, thereby initiating a co-culture; and passaging the co-
culture as necessary into fresh, defined serum-free medium 
supplemented with L-ascorbic acid at least until the motoneu-
rons form Nodes ofRanvier indicative ofmyelination. 
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Another preferred embodiment of the invention includes a 
method of making myelinated motoneurons in vitro, the 
method comprising co-culturing isolated motoneurons and 
Schwarm cells in a defined serum-free medium on a biomi-
metic monolayer supported on a surface; and passaging the 
co-culture as necessary into fresh medium supplemented with 
L-ascorbic acid until the motoneurons are myelinated and 
Nodes ofRanvier are formed thereon. 
4 
(E-H) embryonic MN +SC culture images at day 27, (E) phase 
contrast image of the MN+SC co-culture, (F) NF-H antibody 
staining showing neuronal processes, (G) MBP antibody 
staining revealing a segment of compact myelin in the culture, 
(H) merge image indicating co-localization of the NF-Hand 
MBP antibody staining; scale bars=50 µm; 
FIG. 4 shows the immunocytochemical characterization of 
Node of Ranvier formation on motoneurons; (A) phase con-
trast image of day 29 MN+SC co-culture showing an axonal Additional variations of the invention include wherein the 
biomimetic monolayer in the method comprises a non-bio-
logical substrate of N-1 [3(trimethoxysilyl)propyl]diethylen-
etriamine (DETA). Further, the method may also have a sur-
face that comprises glass and the biomimetic mono layer may 
10 segment and multiple Schwarm cell bodies, (B) MBP and 
vgsc staining indicating node formation, (C) CASPR staining 
indicating paranode formation, (D) vgpc staining indicating 
juxtaparanode formation; scale bar=50 µm; 
be patterned, particularly by photolithography. The biomi-
metic monolayer is preferably covalently attached to the sur-
face. 
FIG. 5 shows a flow diagram of a preferred method of the 
15 invention; and 
Cellular products provided by the invention include an 
isolated motoneuron myelinated in vitro according to the 
methods disclosed. Also included in these products is a cul-
ture of motoneurons myelinated in vitro according to the 20 
given methods, and a mixed culture of isolated Schwarm cells 
and motoneurons in a defined serum-free medium, wherein 
the motoneurons are myelinated. It should be understood that 
the presently described methods are equally useful in remy-
elinating disfunctional motoneurons. 25 
The invention also includes a method of drug discovery in 
a demyelinating disease. This method embodiment includes 
co-culturing isolated motoneurons having a myelination defi-
cit together with isolated normal Schwarm cells in a defined 
serum-free medium on a biomimetic mono layer supported on 30 
a surface. The co-culture is contacted with a drug candidate 
being evaluated for effectiveness in reestablishing normal 
myelination. The co-culture is passaged as necessary into 
fresh medium supplemented with L-ascorbic acid. The drug's 
effectiveness is then evaluated by monitoring the motoneu- 35 
rans for myelination and formation of Nodes of Ranvier 
thereon. 
BRIEF DESCRIPTION OF THE DRAWINGS 
FIG. 6 depicts a flow diagram of another preferred method 
of the invention. 
DETAILED DESCRIPTION OF THE PREFERRED 
EMBODIMENT 
The present invention will now be described more fully 
hereinafter with reference to the accompanying drawings, in 
which preferred embodiments of the invention are shown. 
Unless otherwise defined, all technical and scientific terms 
used herein are intended to have the same meaning as com-
monly understood in the art to which this invention pertains 
and at the time of its filing. Although various methods and 
materials similar or equivalent to those described herein can 
be used in the practice or testing of the present invention, 
suitable methods and materials are described below. How-
ever, the skilled should understand that the methods and 
materials used and described are examples and may not the 
only ones suitable for use in the invention. 
Moreover, it should also be understood that as measure-
ments are subject to inherent variability, any temperature, 
weight, volume, time interval, pH, salinity, molarity or mola-
lity, range, concentration and any other measurements, quan-
tities or numerical expressions given herein are intended to be 
The patent or application file contains at least one drawing 
executed in color. Copies of this patent or patent application 
publication with color drawing(s) will be provided by the 
Office upon request and payment of the necessary fee. 
40 approximate and not exact or critical figures unless expressly 
stated to the contrary. Hence, where appropriate to the inven-
tion and as understood by those of skill in the art, it is proper 
to describe the various aspects of the invention using approxi-
mate or relative terms and terms of degree commonly 
Some of the features, advantages, and benefits of the 
present invention having been stated, others will become 
apparent as the description proceeds when taken in conjunc-
tion with the accompanying drawings in which: 
45 employed in patent applications, such as: so dimensioned, 
about, approximately, substantially, essentially, consisting 
essentially of, comprising, and effective amount. 
Further, any publications, patent applications, patents, and 
other references mentioned herein are incorporated by refer-FIG. 1 shows XPS and contact angle analysis of DETA 
monolayeronglass coverslips: (A) XPS survey spectra analy-
sis of the DETA coverslip, (B) XPS high resolution spectrum 
of Nls peak on DETA coverslip, (C) XPS high resolution 
spectrum ofSi2p peak on DETA coverslip, (D) contact angle 
image of water on a DETA coverslip; 
50 ence in their entirety as if they were part of this specification. 
FIG. 2 depicts phase contrast images of motoneuron+ 55 
Schwarm cell co-cultures; (A) EMN culture image at day 7, 
(B) pure neonatal Schwarm cell culture at day 14 (C) EMN+ 
SC co-culture at day 7 (arrow indicating MN); scale bars=60 
µm; 
However, in case of conflict, the present specification, includ-
ing any definitions, will control. In addition, the materials, 
methods and examples given are illustrative in nature only 
and not intended to be limiting. 
Accordingly, this invention may be embodied in many 
different forms and should not be construed as limited to the 
illustrated embodiments set forth herein. Rather, these illus-
trated embodiments are provided so that this disclosure will 
be thorough, complete, and will fully convey the scope of the 
FIG. 3 provides the immunocytochemical evaluation of the 
myelination of motoneurons by Schwarm cells; ( A-D) embry-
onic MN+SC co-culture images at day 29, (A) phase contrast 
image of the MN+SC co-culture, (B) NF-H antibody staining 
60 invention to those skilled in the art. Other features and advan-
tages of the invention will be apparent from the following 
detailed description, and from the claims. 
of neuronal processes throughout the culture, (C) MBP anti-
body staining showing a segment of compact myelin and the 65 
outline of the Schwarm cell. (D) merge image showing the 
co-localization of the NF-H and MBP antibody staining. 
Materials and Methods 
DETA Surface Preparation and Characterization 
Glass coverslips (VWR 48366067, 22x22 mm2 No. 1) 
were first cleaned using 1:1 HCl-methanol followed by a 
concentrated H2S04 soak for 2 h. The D ETA (United Che mi-
US 8,828,721 Bl 
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cal Technologies Inc. T2910-KG) film was formed by the 
reaction of the cleaned surfaces with a 0.1 % (v/v) mixture of 
the organosilane in freshly distilled toluene (VWR 
BDHl 151). The cleaned surfaces were heated to about 100° 
C. in the organosilane mixture, rinsed with toluene, reheated 5 
to about 100° C. in toluene, and then dried in the oven over-
night (100° C.). Surfaces were characterized by static water 
contact angle measurements using a Rame-Hart Model 250 
goniometer, and by X-ray photoelectron spectroscopy (XPS) 
using an Escalab 200i spectrometer (VG Scientific) by moni- 10 




PBS+5% bovine serum albumin (BSA) for 5 min. rinsed once 
with PBS and then blocked with permeabilization solution+ 
5% donkey serum. The cells were then incubated with pri-
mary antibody solutions in blocking buffer overnight at 4 ° C. 
The following primary antibodies were obtained commer-
cially from Chemicon: anti-neurofilament heavy chain (1: 12, 
000) (AB5539), anti-voltage-gated sodium channel pan 
(1:200) (AB5210), anti-voltage gated potassium channel 
(1:200) (AB5483) and MBP (1:40) (MAB382). The anti-
CASPR antibody (1:500) (sc-14340) was obtained from 
Santa Cruz Biotechnology, Inc. The next day primary anti-
body solutions were aspirated and the cells rinsed three times 
with PBS. Then, Alexa-Fluor 488 nm, 594 nm and 647 nm 
secondary antibodies diluted 1 :200 in blocking solution were Dated pregnant Sprague-Dawley rats were housed in an 
animal facility at the University of Central Florida. All 
research was approved by the Institutional Animal Care and 
Use Committee at the University of Central Florida and con-
formed to NIH guidelines. Pregnant rats were anesthetized 
and sacrificed at embryonic day 15, embryos were removed 
by caesarean section and fetuses dissected under a stereo 
microscope (Carl Zeiss, Stemi, 2000). 
15 added to the cells and incubated for 2 hat room temperature 
in the dark. The secondary antibody solution was then aspi-
rated and the coverslips rinsed three times in PBS and allowed 
to dry. Finally, coverslips were mounted on glass slides using 
VectaShield mounting medium with DAPI (Vector Labs, 
20 H-1200) and fixed using clear nail polish. 
Purified Embryonic Motoneuron Culture 
Rat spinal cord motoneurons were purified from the ventral 
horn cords from embryonic day 15 (E15) embryos as 
described by Henderson et al. [ 18]. Briefly, pregnant rats were 25 
anaesthetized and killed by inhalation of excess C02 . Spinal 
cords were removed from the E15 pups and the ventral horn 
tissue was dissected out and digested in 0.05% trypsin-EDTA 
for 15 min in a 37° C. water bath (Gibco 25300-120). Fol-
lowing incubation, the trypsin-EDTA was aspirated and the 30 
cells suspended in dissection media p 10% FBS and the 
tissue gently triturated. The dissociated cell suspension was 
then centrifuged at 500gfor10 minat 4° C. to pellet the cells. 
Next, the tissue was layered on a density gradient ofOpti-prep 
(Sigma D1556) solution and centrifuged at 500 g for 15 min 35 
at 4 ° C. After centrifugation, the resulting top two bands were 
collected in a 15 ml tube and the pellet discarded. The ventral 
horn cells were then applied to an immuopanning dish coated 
with goat affinity purified antibody to rat IgG and the low 
affinity nerve growth factor receptor p75 (Chemicon 40 
MAB365) in dissection medium for 45 min. This positive 
selection process provides attachment for the motoneurons 
while the other cells remain in suspension. After immuopan-
ning the non-adherent cells were aspirated and the adherent 
motoneurons were removed from the dish in dissection 45 
medium to a 15 ml tube. Lastly, the neurons were pelleted by 
centrifugation at 500 g for 10 min and then resuspended in 
culture medium and plated at 100 cells/mm2 (Table 1). 
Neonatal Schwarm Cell Culture 
Results 
DETA Surface Modification 
The aminosilane, trimethoxy-sily lpropy 1-diethy lenetri-
amine (DETA), functions efficiently as a non-biological sub-
strate due to its self-assembling mono layer properties and the 
multiple amines contained in the terminal group. This group 
confers hydrophilic properties to the surface, and that com-
bined with the partial positive change on the amines at physi-
ological pH make it an ideal surface for neuronal cellular 
attachment and survival. The system is similar to poly-D-
lysine, but has been found to be more robust and consistent 
[ 11]. XPS measurements of the D ETA coated coverslips indi-
cated a complete mono layer formed during the self-assembly 
process (FIG. 1). The normalized area values ofNl s ( 401 and 
399 eV) to the Si 2p312 peaks were stable throughout the study 
at 1500 200 and were similar to previously published results 
(FIG. lA-C) [11, 14, 15, 17, 20]. Static contact angle mea-
surements of 45.6±2 validated the hydrophilicity of the 
DETA surfaces (FIG. lD). Stable XPS readings and contact 
angles across coverslips throughout the study indicate unifor-
mity and reproducibility of the self-assembly of the DETA 
mono layer. 
Myelination Promoting Medium Formulation 
As previously reported, embryonic and adult motoneurons, 
grown in serum-free medium on DETA recovered morpho-
logically and electrically, firing repetitive action potentials 
under patch clamp conditions [12]. In this study, rat moto-
neurons and Schwarm cells were isolated and grown in 
serum-free medium on DETA substrates. The defined 
Primary rat Schwarm cells (SC) were cultured from neo-
natal rat sciatic nerves as described originally by Brockes et 
50 medium formulation described in Table 1 supported the 
growth and development of motoneurons and Schwarm cells 
as shown in FIG. 2. Rat motoneurons and Schwarm cells were 
first individually isolated and grown separately as controls to 
al. [19]. Briefly, sciatic nerves from newly born Sprague-
Dawley (Charles River: Raleigh, N.C.) rat pups were dis-
sected from the hind limb and then digested with 0.3% col-
lagenase in Dulbecco' s modified Eagle's medium (DMEM)+ 55 
10% FBS, forskolin and pituitary extract on poly-L-lysine 
coated 100 mm tissue culture dishes. After two days in cul-
ture, fibroblasts were eliminated using Thyl.1 antibody/ 
complement mediated lysis (Chemicon MAB1406). Purified 
SC cultures were passaged no more than three times before 60 
plating with the embryonic motoneurons for the myelination 
experiments. 
Immunocytochemistry & Laser Scanning Confocal Micros-
copy 
The co-cultures were fixed in fresh 4% paraformaldehyde 
in PBS for 5 min and then rinsed twice with PBS. Next, cells 
were permeabilized with a solution of0.5% Triton-X 100 in 
ensure suitable morphology. In the individual cultures these 
motoneurons developed a singular axonal process and 
branching dendritic field (FIG. 2A). Schwarm cells exhibited 
a spindle-like morphology characteristic of this cell type 
(FIG. 2B). Cultured together, motoneurons and Schwarm 
cells exhibited similar morphologies to the individual cul-
tures (FIG. 2C). Furthermore, with the temporal supplemen-
tation of ascorbic acid, Schwarm cells formed myelin sheaths 
and this also resulted in the subsequent clustering of the nodal 
proteins (FIGS. 3 and 4). 
Immunocytochemical Evaluation and Quantification of 
65 Myelination 
As compact myelin forms around neuronal axons, 
Schwarm cells express MBP as a component of the myelin 
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sheath. Using innnunocytochemistry, MBP expression was 
evaluated as a standard for compact myelin formation in the 
culture system for day 25 to day 30. The neuronal processes 
were imaged using anti-neurofilament-H(NF-H) antibodies 
and then the fluorescence co-localization was determined 
using the two antibodies. Myelin segments were observed in 
motoneuron+Schwann cell co-cultures (FIG. 3). After stain-
ing, myelin segments were quantified in order to determine 
the efficiency of Schwarm cell myelination in the co-culture 
system. As shown in Table 2, 63.11±1.70 myelinated seg- 10 
ments per coverslip were identified in the motoneuron+ 
Schwarm cell co-culture. 
8 
initial segment, it is not known what regulates the Schwarm 
cell "decision" to elongate an initial myelin segment or begin 
the process of forming a new segment. The likely candidate 
are interactions between the motoneuron and the extra-nodal 
proteins of the myelinating Schwarm cell [26]. Due to the 
significant level of physiological development, the system 
also provides a model for further investigation into the poten-
tial molecular differences between Schwarm cell interaction 
withmotoneurons and sensory neurons. For example, it could 
be useful in the evaluation of additional factors that could play 
a role in enhancing motoneuron myelination and node forma-
tion relative to sensory neurons. This is especially true for 
evaluating factors that are normally abundant in serum 
infused medium formulations typically used to facilitate 
Additionally, myelination resulted in the rearrangement 
and clustering of voltage-gated sodium channels (vgsc' s) and 
voltage-gated potassium channels ( vgpc' s) in the axonal seg-
ment. This clustering resulted in the formation of physiologi-
cally correct Nodes of Ranvier as defined below. 
15 Schwarm cell myelination of sensory neurons. 
Node of Ranvier Formation 
DETA's utility from a bioengineering standpoint stems 
from its defined and reproducible nature. Its role here, as a 
biomimetic, hydrophilic growth substrate, is especially use-
ful because we believe it is not degraded by the cells plated on 
20 it and because it easily facilitates the study of deposited 
extracellular matrix molecules on the growth surface by the 
cells. DETA can be coated onto any hydroxylated surface or 
material. All of these features make DETA a useful substrate 
In order to visualize nodal development in this system, 
immunocytochemistry was used to stain for vgsc's, vgpc's 
and CASPR localized at the nodes. As shown in FIG. 4, vgsc' s 
were found clustered between two myelinated segments of a 
motoneuron axon, verifying Node of Ranvier formation 
(FIGS. 4A,B). Additionally, clusters of CASPR (FIG. 4C) 
and vgpc's (FIG. 4D) were also seen in this culture system. 25 
The presence of these nodal proteins indicates maturation of 
the nodes into the physiologically correct morphologies. 
After staining, the number of nodes was quantified in order to 
determine the efficiency of Schwarm cell myelination and 
node formation in the co-culture system. As shown in Table 2, 30 
the formation of20.67±0.61 Nodes ofRanvier was identified 
per coverslip. 
Discussion 
for bioengineering applications, a major goal in hybrid elec-
tronic systems, tissue engineering and cell-based biosensors. 
Consequently, DETA coated micro-electro-mechanical sys-
tems (MEMS) devices like multi-electrode arrays (MEAs) 
can provide a high throughput system for evaluating the elec-
trical differences between myelinated and non-myelinated 
neurons. As previous studies have indicated, the deposition of 
a basal lamina and the subsequent modification of that layer 
are required for the formation of Schwarm cell myelin [ 6, 7, 
27]. Therefore, the use of DETA as the growth substrate for 
these experiments suggests that the neurons and/or the 
35 Schwarm cells are secreting sufficient extracellular matrix 
(ECM) components necessary for the formation of the myelin 
sheath. This raises the questions of which cells generate the 
basal lamina, which cells secrete what ECM proteins, and 
how the ECM deposition influences cell-cell interaction 
The development of an in vitro system defining the mini-
mum requirements for the survival, maturation and myelina-
tion of a motoneuron+Schwann cell co-culture represents a 
significant scientific and technological breakthrough. These 
experiments indicate that this medium formulation is suffi-
cient to not only recover cellular functionality, but also to 
provide an environment conducive to further cell-cell inter-
actions and relevant physiological development that results in 
physiologically correct Node of Ranvier formation. Using 
this basic serum-free medium formulation we have also 
shown the ability to grow dorsal root ganglia sensory neurons 
and both intrafusal and extrafusal muscle fibers [21-23]. The 45 
ability of the same basic serum-free medium formulation to 
sustain growth and facilitate myelination of a variety of inter-
acting cell types facilitates future studies where all cells could 
40 between neurons and Schwarm cells. These questions are 
currently under investigation in our laboratory. 
be combined (Table 1). For example, studying motoneuron/ 
sensory neuron electrical connectivity or recreating the 50 
stretch reflex arc in vitro will require all of these cell types to 
be in close proximity and will be more easily achieved using 
one basic medium formulation. This also is an essential 
requirement for drug discovery applications. Furthermore, 
the reported importance of culturing motoneurons, sensory 55 
neurons and Schwarm cells together with muscle to form a 
significant number of neuromuscular junctions in vitro makes 
this basic medium even more critical [24, 25]. 
Schwarm cell interaction with axons in the periphery is 
essential for efficient myelin sheath formation. Here we have 60 
shown both myelin sheath formation and subsequent devel-
opment of Nodes ofRanvierusing this defined in vitro system 
(FIGS. 3 and 4). The quantity of myelinated segments relative 
to Nodes ofRanvier indicate that not all myelinated segments 
formed in such a fashion as to result in the clustering of nodal 65 
proteins. While the processing of nodal proteins is influenced 
by the presence of myelinating Schwarm cells opposing the 
CONCLUSION 
We have used a completely defined in vitro system to 
demonstrate Node ofRanvier formation by Schwarm cells on 
motoneurons with concurrent K channel clustering and 
CASPR formation. The development of this system, one 
where motoneurons are myelinated by Schwarm cells, is a 
critical breakthrough in understanding the interactions 
between these two cell types and represents significant 
progress towards culturing a stretch reflex arc in vitro [24, 28, 
29]. Additionally, it provides a novel system to evaluate the 
utility of a variety of factors not easily analyzed using an in 
vivo model. Such a system could provide enhancement to or 
recovery of myelin segments for patients suffering from 
demyelinating neuropathies. This defined system provides a 
reproducible model for studying Schwarm cell interactions 
with motoneurons as well as the myelination process, and 
most importantly, remyelination. 
Accordingly, in the drawings and specification there have 
been disclosed typical preferred embodiments of the inven-
tion and although specific terms may have been employed, the 
terms are used in a descriptive sense only and not for purposes 
of limitation. The invention has been described in consider-
able detail with specific reference to these illustrated embodi-
ments. It will be apparent, however, that various modifica-
US 8,828,721 Bl 
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tions and changes can be made within the spirit and scope of 
the invention as described in the foregoing specification and 
as defined in the appended claims. 
TABLE 1 
Serum free medium composition for growth and 
myelination ofmotoneurons by Schwann cells 
Amount/ 
Component Concentration Company 
Neurobasal 500 mL Gib co 
B27 50 µL/ML Gib co 
Glutamax 10 µL/ML Invitrogen 
Antibiotic/ Antimycotic 10 µL/mL Invitrogen 
aFGF 20 ng/mL Invitrogen 
VEGF 165 20 ng/mL Invitrogen 
hBDNF 20 ng/mL Cell Sciences 
hGDNF 20 ng/mL Cell Sciences 
rCNTF 50 ng/mL Cell Sciences 
hCT-1 20 ng/mL Cell Sciences 
NT-3 20 ng/mL Cell Sciences 
NT-4 20 ng/mL Cell Sciences 
Heparin sulfate 80 ng/mL Sigma 
Vitronectin 100 ng/mL Sigma 
1 L-ascorbic acid 50 ng/mL Sigma-Aldrich 























61.67 ± 3.71 
20.33 ± 0.88 
Culture 2 
63.67 ± 4.91 
20.00 ± 1.73 
The data shown is a mean of four coverslips evaluated per culture. 
The values are the mean± the standard error of the mean (SEM). 
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5. The method of claim 4, wherein the covalently attached 
mono layer of N-1 [3(trimethoxysilyl)propyl]diethylenetri-
amine is patterned by photolithography. 
6. An isolated motoneuron myelinated in vitro by a method 
5 comprising co-culturing isolated motoneurons and Schwarm 
cells in a serum-free medium of Table 1 on a surface having 
thereon a covalently attached monolayer ofN-1 [3 ( trimethox-
ysily l)propy l]diethy lenetriamine; and passaging the co-cul-
ture as necessary into fresh serum-free medium of Table 1 
10 supplemented with L-ascorbic acid until the motoneurons are 
myelinated and Nodes ofRanvier are formed thereon. 
7. The isolated motoneuron of claim 6, wherein the 
covalently attached mono layer ofN-1 [3(trimethoxysilyl)pro-
15 pyl]diethylenetriamine is patterned. 
8. The isolated motoneuron of claim 6, wherein the surface 
is glass. 
in cocultures of rat spinal cord explant and human muscle. 20 
J Comp Neural 2001; 438:239-51. 
9. A culture of motoneurons myelinated in vitro by a 
method comprising co-culturing isolated motoneurons and 
Schwarm cells in a serum-free medium of Table 1 on a surface 
having thereon a covalently attached mono layer of N-1 [3 
What is claimed is: 
1. A method of inducing myelination of isolated motoneu-
rons, the method comprising: 
(trimethoxysilyl)propyl]diethylenetriamine; and passaging 
the co-culture as necessary into fresh serum-free medium of 
Table 1 supplemented with L-ascorbic acid until the moto-
preparing a non-biological surface having thereon a 
covalently attached mono layer of N-1 [3 (trimethoxysi-
lyl)propyl]diethylenetriamine; 
25 neurons are myelinated and Nodes of Ranvier are formed 
thereon. 
depositing isolated motoneurons on the surface in a serum-
free medium of Table 1; 
initiating a co-culture by plating isolated Schwarm cells 30 
cultured in the serum-free medium of Table 1 onto the 
motoneurons; and 
passaging the co-culture as necessary into fresh serum-free 
medium ofTable 1 supplemented with L-ascorbic acid at 
least until the motoneurons form Nodes of Ranvier 35 
indicative of myelination. 
2. A method of making myelinated motoneurons in vitro, 
the method comprising: 
10. The culture of motoneurons of claim 9, wherein the 
covalently attached mono layer ofN-1 [3(trimethoxysilyl)pro-
pyl]diethylenetriamine is patterned. 
11. The culture of motoneurons of claim 9, wherein the 
surface is glass. 
12. A mixed culture of isolated Schwarm cells and moto-
neurons in a serum-free medium of Table 1, wherein the 
motoneurons are myelinated. 
13. An isolated dysfunctional motoneuron remyelinated by 
a method-comprising co-culturing isolated motoneurons and 
Schwarm cells in a serum-free medium of Table 1 on a surface 
having thereon a covalently attached mono layer of N-1 [3 co-culturing isolated motoneurons and Schwarm cells in a 
serum-free medium of Table 1 on a surface having 
thereon a covalently attached monolayer ofN-1[3(tri-
methoxysilyl)propyl]diethylenetriamine; and 
40 (trimethoxysilyl)propyl]diethylenetriamine; and passaging 
the co-culture as necessary into fresh serum-free medium of 
Table 1 supplemented with L-ascorbic acid until the moto-
neurons are myelinated and Nodes of Ranvier are formed 
thereon. 
passaging the co-culture as necessary into fresh medium of 
Table 1 supplemented with L-ascorbic acid until the 
motoneurons are myelinated and Nodes of Ranvier are 45 
formed thereon. 
3. The method of claim 2, wherein the surface comprises 
glass. 
4. The method of claim 2, wherein the covalently attached 
monolayer of N-1 [3(trimethoxysilyl)propyl]diethylenetri-
amine is patterned. 
14. The isolated dysfunctional motoneuron of claim 13, 
wherein the covalently attached monolayer of N-1[3(tri-
methoxysilyl)propyl]diethylenetriamine is patterned. 
15. The isolated dysfunctional motoneuron of claim 13, 
50 
wherein the surface is glass. 
* * * * * 
